Unraveling the Mechanism of Epichaperome Modulation by Zelavespib: Biochemical Insights on Target Occupancy and Extended Residence Time at the Site of Action
Authors:
Open Access
- 22 September 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (10) , 2599
Abstract
Drugs with a long residence time at their target sites are often more efficacious in disease treatment. The mechanism, however, behind prolonged retention at the site of action is often difficult to understand for non-covalent agents. In this context, we focus on epichaperome agents, such as zelavespib and icapamespib, which maintain target binding for days despite rapid plasma clearance, minimal retention in non-diseased tissues, and rapid metabolism. They have shown significant therapeutic value in cancer and neurodegenerative diseases by disassembling epichaperomes, which are assemblies of tightly bound chaperones and other factors that serve as scaffolding platforms to pathologically rewire protein–protein interactions. To investigate their impact on epichaperomes in vivo, we conducted pharmacokinetic and target occupancy measurements for zelavespib and monitored epichaperome assemblies biochemically in a mouse model. Our findings provide evidence of the intricate mechanism through which zelavespib modulates epichaperomes in vivo. Initially, zelavespib becomes trapped when epichaperomes bound, a mechanism that results in epichaperome disassembly, with no change in the expression level of epichaperome constituents. We propose that the initial trapping stage of epichaperomes is a main contributing factor to the extended on-target residence time observed for this agent in clinical settings. Zelavespib’s residence time in tumors seems to be dictated by target disassembly kinetics rather than by frank drug–target unbinding kinetics. The off-rate of zelavespib from epichaperomes is, therefore, much slower than anticipated from the recorded tumor pharmacokinetic profile or as determined in vitro using diluted systems. This research sheds light on the underlying processes that make epichaperome agents effective in the treatment of certain diseases.Keywords
Funding Information
- NIH (RF1 AG071805, U01 AG032969, R01 CA172546, P01 CA186866, R01 AG072599, R56 AG061869, R01 AG067598, R01 AG074004, R56 AG072599, P30 CA08748, A2022020F)
- William H. (RF1 AG071805, U01 AG032969, R01 CA172546, P01 CA186866, R01 AG072599, R56 AG061869, R01 AG067598, R01 AG074004, R56 AG072599, P30 CA08748, A2022020F)
- Alice Goodwin (RF1 AG071805, U01 AG032969, R01 CA172546, P01 CA186866, R01 AG072599, R56 AG061869, R01 AG067598, R01 AG074004, R56 AG072599, P30 CA08748, A2022020F)
- Commonwealth Foundation for Cancer Research (RF1 AG071805, U01 AG032969, R01 CA172546, P01 CA186866, R01 AG072599, R56 AG061869, R01 AG067598, R01 AG074004, R56 AG072599, P30 CA08748, A2022020F)
- Experimental Therapeutics Center of MSKCC (RF1 AG071805, U01 AG032969, R01 CA172546, P01 CA186866, R01 AG072599, R56 AG061869, R01 AG067598, R01 AG074004, R56 AG072599, P30 CA08748, A2022020F)
- BrightFocus Foundation (RF1 AG071805, U01 AG032969, R01 CA172546, P01 CA186866, R01 AG072599, R56 AG061869, R01 AG067598, R01 AG074004, R56 AG072599, P30 CA08748, A2022020F)
This publication has 64 references indexed in Scilit:
- Pharmacokinetics and the drug–target residence time conceptDrug Discovery Today, 2013
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survivalDrug Discovery Today, 2012
- Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugsExpert Opinion on Drug Discovery, 2010
- Long‐lasting target binding and rebinding as mechanisms to prolongin vivodrug actionBritish Journal of Pharmacology, 2010
- Drug–target residence time: critical information for lead optimizationCurrent Opinion in Chemical Biology, 2010
- A facile and efficient synthesis of d6‐labeled PU‐H71, a purine‐scaffold Hsp90 inhibitorJournal of Labelled Compounds and Radiopharmaceuticals, 2009
- Analysis of RNA Folding by Native Polyacrylamide Gel Electrophoresis2009
- Drug–target residence time and its implications for lead optimizationNature Reviews Drug Discovery, 2006
- Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90Journal of Medicinal Chemistry, 2005
- Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterizationIn Vitro Cellular & Developmental Biology - Plant, 1978